Aggressive variants of follicular cell-derived thyroid carcinomas: A cytopathologist's perspective

Cancer Cytopathology

Volumn 122, Issue 7, 2014, Pages 484-503

  Lastra, Ricardo R ^a   LiVolsi, Virginia A ^a   Baloch, Zubair W ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aggressive; Carcinoma; Cytology; Fine needle aspiration; Follicular; Thyroid

Indexed keywords

AGGRESSIVE; CARCINOMA; CYTOLOGY; FINE-NEEDLE ASPIRATION; FOLLICULAR; THYROID;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, NEEDLE; HUMANS; PATHOLOGY; PROGNOSIS; THYROID NEOPLASMS;

EID: 84906877147     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21417     Document Type: Review

References (143)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
2. Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A. Aggressive variants of papillary thyroid carcinoma. Head Neck. 2011;33:1052-1059.
3. Baloch Z, LiVolsi VA, Tondon R. Aggressive variants of follicular cell derived thyroid carcinoma; the so called "real thyroid carcinomas." J Clin Pathol. 2013;66:733-743.
4. DeLellis RR, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004.
5. Layfield LJ, Cibas ES, Baloch Z. Thyroid fine needle aspiration cytology: A review of the National Cancer Institute State of the Science Symposium. Cytopathology. 2010;21:75-85.
6. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules, Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
7. Gupta S, Sodhani P, Jain S, Kumar N. Morphologic spectrum of papillary carcinoma of the thyroid: role of cytology in identifying the variants. Acta Cytol. 2004;48:795-800.
8. Kini SR, Miller JM, Hamburger JI, Smith MJ. Cytopathology of papillary carcinoma of the thyroid by fine needle aspiration. Acta Cytol. 1980;24:511-521.
9. Kaur A, Jayaram G. Thyroid tumors: cytomorphology of papillary carcinoma. Diagn Cytopathol. 1991;7:462-468.
10. Lam AK, Lo CY, Lam KS. Papillary carcinoma of thyroid: A 30- year clinicopathological review of the histological variants. Endocr Pathol. 2005;16:323-330.
11. Kazaure HS, Roman SA, Sosa JA. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43, 738 patients. Ann Surg Oncol. 2012;19:1874-1880.
12. Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q. 1976;43:207-215.
13. Ostrowski ML, Merino MJ. Tall cell variant of papillary thyroid carcinoma: A reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol. 1996;20:964-974.
14. Guan H, Vandenbussche CJ, Erozan YS, et al. Can the tall cell variant of papillary thyroid carcinoma be distinguished from the conventional type in fine needle aspirates? A cytomorphologic study with assessment of diagnostic accuracy. Acta Cytol. 2013;57: 534-542.
15. LiVolsi VA. Papillary carcinoma tall cell variant (TCV): A review. Endocr Pathol. 2010;21:12-15.
16. Akslen LA, LiVolsi VA. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer. 2000;88:1902-1908.
17. Bocklage T, DiTomasso JP, Ramzy I, Ostrowski ML. Tall cell variant of papillary thyroid carcinoma: cytologic features and differential diagnostic considerations. Diagn Cytopathol. 1997;17:25-29.
18. Gamboa-Dominguez A, Candanedo-Gonzalez F, Uribe-Uribe NO, Angeles-Angeles A. Tall cell variant of papillary thyroid carcinoma. A cytohistologic correlation. Acta Cytol. 1997;41:672-676.
19. Solomon A, Gupta PK, LiVolsi VA, Baloch ZW. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagn Cytopathol. 2002;27:143-148.
20. Urano M, Kiriyama Y, Takakuwa Y, Kuroda M. Tall cell variant of papillary thyroid carcinoma: its characteristic features demonstrated by fine-needle aspiration cytology and immunohistochemical study. Diagn Cytopathol. 2009;37:732-737.
21. Harach HR, Zusman SB. Cytopathology of the tall cell variant of thyroid papillary carcinoma. Acta Cytol. 1992;36:895-899.
22. Das DK, Mallik MK, Sharma P, et al. Papillary thyroid carcinoma and its variants in fine needle aspiration smears. A cytomorphologic study with special reference to tall cell variant. Acta Cytol. 2004;48: 325-336.
23. Cameselle-Teijeiro J, Febles-Perez C, Cameselle-Teijeiro JF, Alfonsin-Barreiro N, Moldes-Boullosa J, Barreiro F. Cytologic clues for distinguishing the tall cell variant of thyroid papillary carcinoma. A case report. Acta Cytol. 1997;41:1310-1316.
24. Ylagan LR, Dehner LP, Huettner PC, Lu D. Columnar cell variant of papillary thyroid carcinoma. Report of a case with cytologic findings. Acta Cytol. 2004;48:73-77.
25. Jayaram G. Cytology of columnar-cell variant of papillary thyroid carcinoma. Diagn Cytopathol. 2000;22:227-229.
26. Perez F, Llobet M, Garijo G, Barcelo C, Castro P, Bernado L. Fine-needle aspiration cytology of columnar-cell carcinoma of the thyroid: report of 2 cases with cytohistologic correlation. Diagn Cytopathol. 1998;18:352-356.
27. Bongiovanni M, Triponez F, McKee TA, Kumar N, Matthes T, Meyer P. Fine-needle aspiration of the diffuse sclerosing variant of papillary thyroid carcinoma masked by florid lymphocytic thyroiditis; a potential pitfall: A case report and review of the literature. Diagn Cytopathol. 2009;37:671-675.
28. Takagi N, Hirokawa M, Nobuoka Y, Higuchi M, Kuma S, Miyauchi A. Diffuse sclerosing variant of papillary thyroid carcinoma: A study of fine needle aspiration cytology in 20 patients [published online ahead of print June 20, 2013]. Cytopathology. 2013.
29. Odashiro DN, Nguyen GK. Diffuse sclerosing variant papillary carcinoma of the thyroid: report of 4 cases with fine-needle aspirations. Diagn Cytopathol. 2006;34:247-249.
30. Lee JY, Shin JH, Han BK, et al. Diffuse sclerosing variant of papillary carcinoma of the thyroid: imaging and cytologic findings. Thyroid. 2007;17:567-573.
31. Troncone G, Russo M, Malapelle U, et al. Cytological and molecular diagnosis of solid variant of papillary thyroid carcinoma: A case report [serial online]. Cytojournal. 2008;5:2.
32. Chiosea S, Nikiforova M, Zuo H, et al. A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma. Endocr Pathol. 2009;20:122-126.
33. Asioli S, Maletta F, Pagni F, et al. Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review. Diagn Cytopathol. 2014;42:78-84.
34. Bellevicine C, Cozzolino I, Malapelle U, Zeppa P, Troncone G. Cytological and molecular features of papillary thyroid carcinoma with prominent hobnail features: A case report. Acta Cytol. 2012; 56:560-564.
35. Yan Z, Yang GC, Waisman J. A low-power, "architectural, " clue to the follicular variant of papillary thyroid adenocarcinoma in aspiration biopsy. Acta Cytol. 2000;44:211-217.
36. Gallagher J, Oertel YC, Oertel JE. Follicular variant of papillary carcinoma of the thyroid: fine-needle aspirates with histologic correlation. Diagn Cytopathol. 1997;16:207-213.
37. Logani S, Gupta PK, LiVolsi VA, Mandel S, Baloch ZW. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management. Diagn Cytopathol. 2000;23:380-385.
38. Yang GC, Liebeskind D, Messina AV. Diagnostic accuracy of follicular variant of papillary thyroid carcinoma in fine-needle aspirates processed by ultrafast Papanicolaou stain: histologic follow-up of 125 cases. Cancer Cytopathol. 2006;108:174-179.
39. Wu HH, Jones JN, Grzybicki DM, Elsheikh TM. Sensitive cytologic criteria for the identification of follicular variant of papillary thyroid carcinoma in fine-needle aspiration biopsy. Diagn Cytopathol. 2003;29:262-266.
40. Bongiovanni M, Sadow PM, Faquin WC. Poorly differentiated thyroid carcinoma: A cytologic-histologic review. Adv Anat Pathol. 2009;16:283-289.
41. Bongiovanni M, Bloom L, Krane JF, et al. Cytomorphologic features of poorly differentiated thyroid carcinoma: A multiinstitutional analysis of 40 cases. Cancer Cytopathol. 2009;117:185- 194.
42. Pietribiasi F, Sapino A, Papotti M, Bussolati G. Cytologic features of poorly differentiated "insular" carcinoma of the thyroid, as revealed by fine-needle aspiration biopsy. Am J Clin Pathol. 1990; 94:687-692.
43. Luze T, Totsch M, Bangerl I, et al. Fine needle aspiration cytodiagnosis of anaplastic carcinoma and malignant haemangioendothelioma of the thyroid in an endemic goiter area. Cytopathology. 1990;1:305-310.
44. Guarda LA, Peterson CE, Hall W, Baskin HJ. Anaplastic thyroid carcinoma: cytomorphology and clinical implications of fine-needle aspiration. Diagn Cytopathol. 1991;7:63-67.
45. Us-Krasovec M, Golouh R, Auersperg M, Besic N, Ruparcic- Oblak L. Anaplastic thyroid carcinoma in fine needle aspirates. Acta Cytol. 1996;40:953-958.
46. Rivera M, Sang C, Gerhard R, Ghossein R, Lin O. Anaplastic thyroid carcinoma: morphologic findings and PAX-8 expression in cytology specimens. Acta Cytol. 2010;54:668-672.
47. Ghossein R, LiVolsi VA. Papillary thyroid carcinoma tall cell variant. Thyroid. 2008;18:1179-1181.
48. Ghossein R, Ganly I, Biagini A, Robenshtok E, Rivera M, Tuttle RM. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: A clinicopathologic study of 148 cases. Thyroid. 2014;24:245-253.
49. Ghossein RA, Leboeuf R, Patel KN, et al. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications. Thyroid. 2007;17:655-661.
50. Nikiforova MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab. 2003;88:5399-5404.
51. Virk RK, Van Dyke AL, Finkelstein A, et al. BRAF V600E mutation in papillary thyroid microcarcinoma: A genotype-phenotype correlation. Mod Pathol. 2013;26:62-70.
52. Liu X, Bishop J, Shan Y, et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer. 2013; 20:603-610.
53. Wreesmann VB, Sieczka EM, Socci ND, et al. Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res. 2004;64:3780-3789.
54. Campo E, Merino MJ, Liotta L, Neumann R, Stetler-Stevenson W. Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue. Hum Pathol. 1992;23:1395-1401.
55. Basolo F, Giannini R, Monaco C, et al. Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. Am J Pathol. 2002;160:247- 254.
56. Filie AC, Chiesa A, Bryant BR, Merino MJ, Sobel ME, Abati A. The tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms. Cancer Cytopathol. 1999;87: 238-242.
57. Lee A, LiVolsi VA, Baloch ZW. Expression of DNA topoisomerase IIalpha in thyroid neoplasia. Mod Pathol. 2000;13:396-400.
58. Roque L, Clode AL, Gomes P, Rosa-Santos J, Soares J, Castedo S. Cytogenetic findings in 31 papillary thyroid carcinomas. Genes Chromosomes Cancer. 1995;13:157-162.
59. Evans HL. Columnar-cell carcinoma of the thyroid. A report of 2 cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol. 1986;85:77-80.
60. Gaertner EM, Davidson M, Wenig BM. The columnar cell variant of thyroid papillary carcinoma. Case report and discussion of an unusually aggressive thyroid papillary carcinoma. Am J Surg Pathol. 1995;19:940-947.
61. Sobrinho-Simoes M, Nesland JM, Johannessen JV. Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol. 1988;89:264-267.
62. Barton CP 3rd, Brennan JA, Lowry TR, Russell MJ. Columnar cell variant of papillary thyroid carcinoma. Ear Nose Throat J. 2006;85:640, 643.
63. Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS. Thyroid papillary carcinoma of columnar cell type: A clinicopathologic study of 16 cases. Cancer. 1998;82:740-753.
64. LiVolsi VA. Surgical Pathology of the Thyroid. Philadelphia, PA: WB Saunders; 1990.
65. LiVolsi VA. Unusual variants of papillary thyroid carcinoma. Adv Endocrinol Metab. 1995;6:39-54.
66. Enriquez ML, Baloch ZW, Montone KT, Zhang PJ, LiVolsi VA. CDX2 expression in columnar cell variant of papillary thyroid carcinoma. Am J Clin Pathol. 2012;137:722-726.
67. Evans HL. Encapsulated columnar-cell neoplasms of the thyroid. A report of 4 cases suggesting a favorable prognosis. Am J Surg Pathol. 1996;20:1205-1211.
68. Chen JH, Faquin WC, Lloyd RV, Nose V. Clinicopathological and molecular characterization of 9 cases of columnar cell variant of papillary thyroid carcinoma. Mod Pathol. 2011;24:739-749.
69. Vickery AL Jr, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M. Papillary carcinoma. Semin Diagn Pathol. 1985;2:90-100.
70. Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol. 1989;13:1041-1049.
71. Moreno Egea A, Rodriguez Gonzalez JM, Sola Perez J, Soria T, Parrilla Paricio P. Clinicopathological study of the diffuse sclerosing variety of papillary cancer of the thyroid. Presentation of 4 new cases and review of the literature. Eur J Surg Oncol. 1994;20:7-11.
72. Soares J, Limbert E, Sobrinho-Simoes M. Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases. Pathol Res Pract. 1989;185:200-206.
73. Albareda M, Puig-Domingo M, Wengrowicz S, et al. Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid. 1998;8:385-391.
74. Fukushima M, Ito Y, Hirokawa M, Akasu H, Shimizu K, Miyauchi A. Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: An 18-year experience at a single institution. World J Surg. 2009;33: 958-962.
75. Koo JS, Hong S, Park CS. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young. Thyroid. 2009;19:1225-1231.
76. Wu PS, Leslie PJ, McLaren KM, Toft AD. Diffuse sclerosing papillary carcinoma of thyroid: A wolf in sheep's clothing. Clin Endocrinol (Oxf). 1989;31:535-540.
77. McElvanna K, McCusker G, Stirling I. Diffuse sclerosing variant of papillary thyroid carcinoma-a rare cause of goitre in a young patient. Ulster Med J. 2007;76:113-114.
78. Thompson LD, Wieneke JA, Heffess CS. Diffuse sclerosing variant of papillary thyroid carcinoma: A clinicopathologic and immunophenotypic analysis of 22 cases. Endocr Pathol. 2005;16:331-348.
79. LiVolsi VA. Papillary thyroid carcinoma: An update. Mod Pathol. 2011;24(suppl 2):S1-S9.
80. Zhang Y, Xia D, Lin P, Gao L, Li G, Zhang W. Sonographic findings of the diffuse sclerosing variant of papillary carcinoma of the thyroid. J Ultrasound Med. 2010;29:1223-1226.
81. Pino Rivero V, Pardo Romero G, Gonzalez Palomino A, et al. Diffuse sclerosing papillary carcinoma mimicking chronic lymphocytic thyroiditis. An unusual neoplasm variant. Ann Otorhinolaringol Ibero Am. 2006;33:347-353.
82. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 1997;57:1690-1694.
83. Sheu SY, Schwertheim S, Worm K, Grabellus F, Schmid KW. Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. Mod Pathol. 2007;20:779-787.
84. Thomas GA, Bunnell H, Cook HA, et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post- Chernobyl thyroid papillary carcinomas: A strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab. 1999;84:4232-4238.
85. Salvatore G, Giannini R, Faviana P, et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2004;89:5175-5180.
86. Lin X, Finkelstein SD, Zhu B, Silverman JF. Molecular analysis of multifocal papillary thyroid carcinoma. J Mol Endocrinol. 2008;41: 195-203.
87. Rocha AS, Soares P, Seruca R, et al. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol. 2001;194:358-366.
88. Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV. Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol. 2001;25:1478-1484.
89. Fridman MV, Savva NN, Krasko OV, et al. Clinical and pathologic features of "sporadic" papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus. Thyroid. 2012;22:1016-1024.
90. LiVolsi VA, Abrosimov AA, Bogdanova T, et al. The Chernobyl thyroid cancer experience: pathology. Clin Oncol (R Coll Radiol). 2011;23:261-267.
91. Nikiforov Y, Gnepp DR. Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer. 1994;74:748-766.
92. Collini P, Mattavelli F, Pellegrinelli A, Barisella M, Ferrari A, Massimino M. Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis: A clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol. 2006;30:1420-1426.
93. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol. 1999;23:205-211.
94. Tallini G, Santoro M, Helie M, et al. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res. 1998;4:287-294.
95. Trovisco V, Soares P, Soares R, Magalhaes J, Sa-Couto P, Sobrinho-Simoes M. A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Hum Pathol. 2005;36:694-697.
96. Motosugi U, Murata S, Nagata K, Yasuda M, Shimizu M. Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: A histological variant with intermediate malignancy? Thyroid. 2009;19:535-537.
97. Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: A new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of 8 cases. Am J Surg Pathol. 2010;34:44-52.
98. Yang GC, Fried K, Scognamiglio T. Cytological features of clear cell thyroid tumors, including a papillary thyroid carcinoma with prominent hobnail features. Diagn Cytopathol. 2013;41:757-761.
99. Asioli S, Erickson LA, Righi A, Lloyd RV. Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol. 2013;44:320-328.
100. Albores-Saavedra J. Papillary thyroid carcinoma with prominent hobnail features: A new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of 8 cases [letter]. Am J Surg Pathol. 2010;34:913; author reply 914.
101. Rosai J, Carcangui ML, DeLellis RA. Tumors of the Thyroid Gland. Washington, DC: Armed Forces Institute of Pathology; 1992.
102. Lubitz CC, Economopoulos KP, Pawlak AC, et al. Hobnail variant of papillary thyroid carcinoma: An institutional case series and molecular profile [published online ahead of print January 13, 2013]. Thyroid. 2014.
103. Ivanova R, Soares P, Castro P, Sobrinho-Simoes M. Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: A clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Virchows Arch. 2002;440:418-424.
104. Lindsay S. Carcinoma of the Thyroid Gland: A Clinical and Pathologic Study of 293 Patients at the University of California Hospital. Springfield, IL: Charles C. Thomas Publisher; 1960.
105. Chem KT, Rosai J. Follicular variant of thyroid papillary carcinoma: A clinicopathologic study of 6 cases. Am J Surg Pathol. 1977;1:123-130.
106. Sobrinho-Simoes M, Soares J, Carneiro F, Limbert E. Diffuse follicular variant of papillary carcinoma of the thyroid: report of 8 cases of a distinct aggressive type of thyroid tumor. Surg Pathol. 1990;3:189-203.
107. Mizukami Y, Nonomura A, Michigishi T, Ohmura K, Noguchi M, Ishizaki T. Diffuse follicular variant of papillary carcinoma of the thyroid. Histopathology. 1995;27:575-577.
108. Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: A clinicopathologic study of a problematic entity. Cancer. 2006;107:1255-1264.
109. Chan JK, Tsang WY. Endocrine malignancies that may mimic benign lesions. Semin Diagn Pathol. 1995;12:45-63.
110. Gupta S, Ajise O, Dultz L, et al. Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities. Arch Otolaryngol Head Neck Surg. 2012;138:227-233.
111. Rivera M, Ricarte-Filho J, Knauf J, et al. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol. 2010;23:1191-1200.
112. Granner DK, Buckwalter JA. Poorly differentiated carcinoma of the thyroid gland. Surg Gynecol Obstet. 1963;116:650-656.
113. Sanders EM Jr, LiVolsi VA, Brierley J, Shin J, Randolph GW. An evidence-based review of poorly differentiated thyroid cancer. World J Surg. 2007;31:934-945.
114. Omur O, Baran Y. An update on molecular biology of thyroid cancers [published online ahead of print December 18, 2013]. Crit Rev Oncol Hematol. 2013.
115. Asioli S, Erickson LA, Righi A, et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol. 2010;23:1269-1278.
116. Kakudo K, Bai Y, Katayama S, et al. Classification of follicular cell tumors of the thyroid gland: Analysis involving Japanese patients from 1 institute. Pathol Int. 2009;59:359-367.
117. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer. 1983;52:1849-1855.
118. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "Wuchernde Struma." Am J Surg Pathol. 1984;8:655-668.
119. Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: The Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31:1256-1264.
120. Volante M, Landolfi S, Chiusa L, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: A clinicopathologic study of 183 patients. Cancer. 2004;100:950- 957.
121. Dettmer M, Schmitt A, Steinert H, et al. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am J Surg Pathol. 2011;35:1866-1872.
122. Tallini G. Poorly differentiated thyroid carcinoma. are we there yet? Endocr Pathol. 2011;22:190-194.
123. Volante M, Rapa I, Gandhi M, et al. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab. 2009;94:4735-4741.
124. Perri F, Lorenzo GD, Scarpati GD, Buonerba C. Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options. World J Clin Oncol. 2011;2:150-157.
125. Chiacchio S, Lorenzoni A, Boni G, Rubello D, Elisei R, Mariani G. Anaplastic thyroid cancer: prevalence, diagnosis and treatment. Minerva Endocrinol. 2008;33:341-357.
126. Bhatia A, Rao A, Ang KK, et al. Anaplastic thyroid cancer: clinical outcomes with conformal radiotherapy. Head Neck. 2010;32: 829-836.
127. Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol. 1985;83:135-158.
128. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53, 856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer. 1998;83:2638-2648.
129. Kitamura Y, Shimizu K, Nagahama M, et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab. 1999;84:4043-4049.
130. Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 2005;103:1330-1335.
131. Neff RL, Farrar WB, Kloos RT, Burman KD. Anaplastic thyroid cancer. Endocrinol Metab Clin North Am. 2008;37:525-538, xi.
132. Pierie JP, Muzikansky A, Gaz RD, Faquin WC, Ott MJ. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg. Oncol. 2002;9:57-64.
133. Edge SB, Byrd DR, Compton CC, et al. eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
134. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer. 1990;66:321-330.
135. Valand AG, Ramraje SN, Pandeya BS, Shedge R, Aware S. Anaplastic thyroid carcinoma with osteoclast-like giant cells. J Assoc Physicians India. 2004;52:585-586.
136. Kobayashi S, Yamadori I, Ohmori M, Kurokawa T, Umeda M. Anaplastic carcinoma of the thyroid with osteoclast-like giant cells. An ultrastructural and immunohistochemical study. Acta Pathol Jpn. 1987;37:807-815.
137. Canos JC, Serrano A, Matias-Guiu X. Paucicellular variant of anaplastic thyroid carcinoma: report of 2 cases. Endocr Pathol. 2001;12:157-161.
138. Wan SK, Chan JK, Tang SK. Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Reidel's thyroiditis. Am J Clin Pathol. 1996;105:388-393.
139. LiVolsi VA, Brooks JJ, Arendash-Durand B. Anaplastic thyroid tumors. Immunohistology. Am J Clin Pathol. 1987;87:434-442.
140. Bishop JA, Sharma R, Westra WH. PAX8 immunostaining of anaplastic thyroid carcinoma: A reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck. Hum Pathol. 2011;42:1873-1877.
141. Borbone E, Troncone G, Ferraro A, et al. Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas. J Clin Endocrinol Metab. 2011;96:1029-1038.
142. Esposito F, Tornincasa M, Pallante P, et al. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2 [serial online]. J Clin Endocrinol Metab. 2012;97:E710-E718.
143. Fassina A, Cappellesso R, Simonato F, et al. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears. Cancer Cytopathol. 2014; doi: 10.1002/cncy.21417.